Načítá se...
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies
Gastrointestinal cancers encompass a diverse class of tumors arising in the GI tract, including esophagus, stomach, pancreas and colorectum. Collectively, gastrointestinal cancers compose a high fraction of all cancer deaths, highlighting an unmet need for novel and effective therapies. In this cont...
Uloženo v:
| Vydáno v: | Biomark Med |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8293028/ https://ncbi.nlm.nih.gov/pubmed/33470843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm-2020-0359 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|